|Application ||WB, E|
|Calculated MW||46558 Da|
|Antigen Region||1-30 aa|
|Other Names||Serine/threonine-protein kinase 17A, DAP kinase-related apoptosis-inducing protein kinase 1, STK17A, DRAK1|
|Target/Specificity||This DRAK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human DRAK1.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||DRAK1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species.|
|Tissue Location||Highly expressed in placenta. Lower levels in heart, lung, skeletal muscle, kidney and pancreas|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
DRAK1 is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Sanjo, H., et al., J. Biol. Chem. 273(44):29066-29071 (1998).
If you have any additional inquiries please email technical services at email@example.com.